NCT05416333View on ClinicalTrials.gov

Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Central Centrifugal Cicatricial Alopecia
Interventions
DRUG

azelaic acid

Subjects will use the topical formulation once daily on the scalp. The subjects will use the treatment for a total of 6 months

OTHER

usual medication for CCCA

Subjects will continue to use their already prescribed topical formulation once daily on the scalp. The subjects will use their treatment for a total of 6 months

Trial Locations (1)

27157

RECRUITING

Wake Forest University Health Scieces, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER